pubmed.ncbi.nlm.nih.gov

To screen or not to screen? Celiac antibodies in liver diseases - PubMed

️Sun Jan 01 2017

Review

To screen or not to screen? Celiac antibodies in liver diseases

Janaína Luz Narciso-Schiavon et al. World J Gastroenterol. 2017.

Abstract

Celiac disease (CD) is a systemic immune-mediated disorder triggered by dietary gluten in genetically predisposed individuals. The typical symptoms are anemia, diarrhea, fatigue, weight loss, and abdominal pain. CD has been reported in patients with primary sclerosing cholangitis, primary biliary cholangitis, autoimmune hepatitis, aminotransferase elevations, nonalcoholic fatty liver disease, hepatitis B, hepatitis C, portal hypertension and liver cirrhosis. We evaluate recommendations for active screening for CD in patients with liver diseases, and the effect of a gluten-free diet in these different settings. Active screening for CD is recommended in patients with liver diseases, particularly in those with autoimmune disorders, steatosis in the absence of metabolic syndrome, noncirrhotic intrahepatic portal hypertension, cryptogenic cirrhosis, and in the context of liver transplantation. In hepatitis C, diagnosis of CD can be important as a relative contraindication to interferon use. Gluten-free diet ameliorates the symptoms associated with CD; however, the associated liver disease may improve, remain the same, or progress.

Keywords: Autoimmune; Biliary; Celiac disease; Cholangitis; Hepatitis; Hypertension; Liver cirrhosis; Portal; Sclerosing.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: None declared.

Cited by

Celiac disease screening in patients with cryptogenic cirrhosis.
Narciso-Schiavon JL, Schiavon LL. Narciso-Schiavon JL, et al. World J Gastroenterol. 2023 Jan 14;29(2):410-412. doi: 10.3748/wjg.v29.i2.410. World J Gastroenterol. 2023. PMID: 36687121 Free PMC article.
Non-celiac gluten sensitivity: All wheat attack is not celiac.
Igbinedion SO, Ansari J, Vasikaran A, Gavins FN, Jordan P, Boktor M, Alexander JS. Igbinedion SO, et al. World J Gastroenterol. 2017 Oct 28;23(40):7201-7210. doi: 10.3748/wjg.v23.i40.7201. World J Gastroenterol. 2017. PMID: 29142467 Free PMC article. Review.
Fatty liver and celiac disease: Why worry?
Narciso-Schiavon JL, Schiavon LL. Narciso-Schiavon JL, et al. World J Hepatol. 2023 May 27;15(5):666-674. doi: 10.4254/wjh.v15.i5.666. World J Hepatol. 2023. PMID: 37305374 Free PMC article. Review.
Celiac Disease: Extraintestinal Manifestations and Associated Conditions.
Therrien A, Kelly CP, Silvester JA. Therrien A, et al. J Clin Gastroenterol. 2020 Jan;54(1):8-21. doi: 10.1097/MCG.0000000000001267. J Clin Gastroenterol. 2020. PMID: 31513026 Free PMC article. Review.
Joint Analysis of Genetic Correlation, Mendelian Randomization and Colocalization Highlights the Bi-Directional Causal Association Between Hypothyroidism and Primary Biliary Cirrhosis.
Wang Y, Guo P, Zhang Y, Liu L, Yan R, Yuan Z, Song Y. Wang Y, et al. Front Genet. 2021 Oct 4;12:753352. doi: 10.3389/fgene.2021.753352. eCollection 2021. Front Genet. 2021. PMID: 34671386 Free PMC article.

References

1. Spijkerman M, Tan IL, Kolkman JJ, Withoff S, Wijmenga C, Visschedijk MC, Weersma RK. A large variety of clinical features and concomitant disorders in celiac disease - A cohort study in the Netherlands. Dig Liver Dis. 2016;48:499–505. - PubMed
1. Di Sabatino A, Corazza GR. Coeliac disease. Lancet. 2009;373:1480–1493. - PubMed
1. Leffler DA, Green PH, Fasano A. Extraintestinal manifestations of coeliac disease. Nat Rev Gastroenterol Hepatol. 2015;12:561–571. - PubMed
1. Narciso JL, Cabral VLR. Regression of subcutaneous sarcoid nodule and disappearance of thyroid-related autoantibodies with a gluten-free diet. GED gastroenterol endosc dig. 2006;25:170–172.
1. Freeman HJ. Endocrine manifestations in celiac disease. World J Gastroenterol. 2016;22:8472–8479. - PMC - PubMed

To screen or not to screen? Celiac antibodies in liver diseases - PubMed